Article

You have full text access to this OnlineOpen article

Structure and interaction of ubiquitin-associated domain of human Fas-associated factor 1†

  1. JinSue Song1,2,‡,
  2. Joon Kyu Park3,4,‡,
  3. Jae-Jin Lee5,
  4. Yun-Seok Choi1,6,
  5. Kyoung-Seok Ryu1,
  6. Jae-Hong Kim4,
  7. Eunhee Kim7,
  8. Kong-Joo Lee5,
  9. Young-Ho Jeon1,6,*,
  10. Eunice EunKyeong Kim3,*

Article first published online: 31 AUG 2009

DOI: 10.1002/pro.237

Issue

Protein Science

Protein Science

Volume 18, Issue 11, pages 2265–2276, November 2009

Additional Information

How to Cite

Song, J., Park, J. K., Lee, J.-J., Choi, Y.-S., Ryu, K.-S., Kim, J.-H., Kim, E., Lee, K.-J., Jeon, Y.-H. and Kim, E. E. (2009), Structure and interaction of ubiquitin-associated domain of human Fas-associated factor 1. Protein Science, 18: 2265–2276. doi: 10.1002/pro.237

Author Information

  1. 1

    Magnetic Resonance Team, Korea Basic Science Institute, 804-1 Yangchung-Ri, Ochang, Chungbuk, Korea 363-883

  2. 2

    College of Pharmacy, Chungbuk National University, 12, Gaeshin-dong, Heungduk-gu, Cheongju, Chungbuk, Korea 361-763

  3. 3

    Life Sciences Division, Korea Institute of Science and Technology, 39-1, Hawolgok-dong, Sungbuk-gu, Seoul, Korea 136-791

  4. 4

    School of Life Sciences and Biotechnology, Korea University, Anam-dong, Sungbuk-gu, Seoul, Korea 136-701

  5. 5

    College of Pharmacy and Division of Life & Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea 120-750

  6. 6

    Department of Bio-Analytical Science, University of Science and Technology, Gwahangno 113, Yusong-gu, Taejon 305-333, Korea

  7. 7

    Department of Biology, Chungnam National University, Daejeon 305-764 Korea

  1. ‡

    The first two authors contributed equally to this work.

*Magnetic Resonance Team, Korea Basic Science Institute, 804-1 Yangchung-Ri, Ochang, Chungbuk, Korea 363-883

  1. †

    Abbreviations: hFAF1, human Fas-associated factor 1; Ub, Ubiquitin; di-Ub, Lys48-linked di-ubiquitin; RMSD, root mean square deviation; CSP, chemical shift perturbation.

Publication History

  1. Issue published online: 23 OCT 2009
  2. Article first published online: 31 AUG 2009
  3. Accepted manuscript online: 31 AUG 2009 12:00AM EST
  4. Manuscript Accepted: 15 AUG 2009
  5. Manuscript Revised: 14 AUG 2009
  6. Manuscript Received: 11 APR 2009

Funded by

  • Functional Proteomics Center
  • 21C Frontier Research & Development Program of the Korea Ministry of Science and Technology, the Korea Institute of Science and Technology Institutional Program Grant
  • Top-Brand Research Program (T29220) of Korea Basic Science Institute
  • KOSEF Grant to the Center for Cell Signaling and Drug Discovery Research at Ewha Womans University
  • CCS & DDR. Grant Number: R15-2006-020

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (951K)

References

  • 1
    Chu K, Niu X, Williams LT ( 1995) Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci USA 92: 11894–11898.
  • 2
    Ryu SW, Chae SK, Lee KJ, Kim E ( 1999) Identification and characterization of human Fas associated factor 1, hFAF1. Biochem Biophys Res Commun 262: 388–394.
  • 3
    De Zio D, Ferraro E, D'amelio M, Simoni V, Bordi M, Soroldoni D, Berghella L, Meyer BI, Cecconi F ( 2008) Faf1 is expressed during neurodevelopment and is involved in Apaf1-dependent caspase-3 activation in proneural cells. Cell Mol Life Sci 65: 1780–1790.
  • 4
    Ryu SW, Lee SJ, Park MY, Jun JI, Jung YK, Kim E ( 2003) Fas-associated factor 1, FAF1, is a member of Fas death-inducing signaling complex. J Biol Chem 278: 24003–24010.
  • 5
    Park MY, Ryu SW, Kim KD, Lim JS, Lee ZW, Kim E ( 2005) Fas-associated factor-1 mediates chemotherapeutic-induced apoptosis via death effector filament formation. Int J Cancer 115: 412–418.
  • 6
    Park MY, Jang HD, Lee SY, Lee KJ, Kim E ( 2004) Fas-associated Factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB. J Biol Chem 279: 2544–2549.
  • 7
    Kim M, Lee JH, Lee SY, Kim E, Chung J ( 2006) Caspar, a suppressor of antibacterial immunity in Drosophila. Proc Natl Acad Sci USA 103: 16358–16363.
  • 8
    Park MY, Moon JH, Lee KS, Choi HI, Chung J, Hong HJ, Kim E ( 2007) FAF1 suppresses IkB kinase (IKK) activation by disrupting the IKK complex assembly. J Biol Chem 282: 27572–27577.
  • 9
    Jang MS, Sul JW, Choi BJ, Lee SJ, Suh JH, Kim NS, Kim WH, Lim DS, Lee CW, Kim E ( 2008) Negative feedback regulation of Aurora-A via phosphorylation of Fas-associated factor-1. J Biol Chem 283: 32343–32351.
  • 10
    Altomare DA, Menges CW, Pei J, Zhang L, Skele-Stump KL, Carbone M, Kane AB, Testa JR ( 2009) Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice. Proc Natl Acad Sci USA 106: 3420–3425.
  • 11
    Song EJ, Yim SH, Kim E, Kim NS, Lee KJ ( 2005) Human Fas assocated factor 1, interacting with ubiquitinated proteins and valosin-containing protein, is involved in ubiquitin-proteasome pathway. Mol Cell Biol 25: 2511–2524.
  • 12
    Kim HJ, Song EJ, Lee YS, Kim E, Lee KJ ( 2005) Human Fas-associated factor 1 interacts with heat shock protein 70 and negatively regulates chaperone activity. J Biol Chem 280: 8125–8133.
  • 13
    Hofmann K, Bucher P ( 1996) The UBA domains: a sequence motif present in multiple enzyme classes of the ubiqutination pathway. Trends Biochem Sci 21: 172–173.
  • 14
    Wilkinson CR, Seeger M, Hatmann-Petersen R, Stone M, Wallace M, Semple C, Gordon C ( 2001) Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol 3: 9732–9742.
  • 15
    Mueller TD, Kamionka M, Feigon J ( 2004) Specificity of the Interaction between Ubiquitin associated domains and Ubiquitin. J Biol Chem 279: 11926–11936.
  • 16
    Hicke L, Schubert HL, Hill CP ( 2005) Ubiquitin-binding domains. Nat Rev Mol Cell Biol 6: 610–621.
  • 17
    Trempe JF, Brown NR, Lowe ED, Gordon C, Campbell ID, Noble ME, Endicott JA ( 2005) Mechanism of Lys48-linked polyubiquitin chain recognition by the Mud1 UBA domain. EMBO J 24: 3178–3189.
  • 18
    Varadan R, Assfalg M, Raasi S, Pickart C, Fushman D ( 2005) Structural determinants for selective recognition of a Lys48-linked polyubiquitin chain by a UBA domain. Mol Cell 18: 687–698.
  • 19
    Raasi S, Varadan R, Fushman D, Pickart CM ( 2005) Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nat Struct Mol Biol 12: 708–714.
  • 20
    Ohno A, Jee J, Fujiwara K, Tenno T, Goda N, Tochio H, Kobayashi H, Hiroaki H, Shirakawa M ( 2005) Structure of the UBA domain of Dsk2p in complex with ubiquitin molecular determinants for ubiquitin recognition. Structure 13: 521–532.
  • 21
    Long J, Gallagher TR, Cavey JR, Sheppard PW, Ralston SH, Layfield R, Searle MS ( 2008) Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. J Biol Chem 283: 5427–5440.
  • 22
    Yuan X, Simpson P, Mckeown C, Kondo H, Uchiyama K, Wallis R, Dreveny I, Keetch C, Zhang X, Robinson C, Freemont P, Matthews S ( 2004) Structure, dynamics and interactions of p47, a major adaptor of the AAA ATPase, p97. EMBO J 23: 1463–1473.
  • 23
    Schuberth C, Richly H, Rumpf S, Buchbeger A ( 2004) Shp1 and Ubx2 are adaptors of Cdc48 involved in ubiquitin-dependent protein degradation. EMBO Rep 5: 818– 824.
  • 24
    Swanson KA, Hicke L, Radhakrishnan I ( 2006) Structural basis for monoubiquitin recognition by the Ede1 UBA domain. J Mol Biol 358: 713–724.
  • 25
    Kozlov G, Nguyen L, Lin T, De Crescenzo G, Park M, Gehring K ( 2007) Structural basis of ubiquitin recognition by the ubiquitin-associated (UBA) domain of the ubiquitin ligase EDD. J Biol Chem 282: 35787–35795.
  • 26
    Zhang D, Raasi S, Fushman D ( 2009) Affinity makes the difference: nonselective interaction of the UBA domain of Ubiquilin-1 with monomeric ubiquitin and polyubiquitin chains. J Mol Biol 377: 162–180.
  • 27
    Hobeika M, Brockmann C, Iglesias N, Gwizdek C, Neuhaus D, Stutz F, Stewart M, Divita G, Dargemont C ( 2007) Coordination of Hpr1 and ubiquitin binding by the UBA domain of the mRNA export factor Mex67. Mol Biol Cell 18: 2561–2568.
  • 28
    Cook WJ, Jeffrey LC, Carson M, Chen Z, Pickart CM ( 1992) Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J Biol Chem 267: 16467–16471.
  • 29
    Ryu KS, Choi YS, Ko J, Kim SO, Kim HJ, Cheong HK, Jeon YH, Choi BS, Cheong C ( 2008) Direct characterization of E2-dependent target specificity and processivity using an artificial p27-linker-E2 ubiquitination system. BMB Rep 41: 852–857.
  • 30
    Whitby FG, Xia G, Pickart CM, Hill CP ( 1998) Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J Biol Chem 273: 34983–34991.
  • 31
    Pickart CM, Haldeman MT, Kasperek EM, Chen Z ( 1992) Iodination of tyrosine 59 of ubiquitin selectively blocks ubiquitin's acceptor activity in diubiquitin synthesis catalyzed by E2(25K). J Biol Chem 267: 14418–14423.
  • 32
    Otwinowski Z, Minor W ( 1997) Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol 276: 307–326.
  • 33
    Emsley P, Cowtan K ( 2004) Coot: model-building tools for molecular graphics. Acta Crystallogr Sect D 60: 2126–2123.
  • 34
    Brunger AT, Adams PD, Clore GM, Delano WL, Gros P, Grosse-Kunstlever RW, Jian JS, Kuszewki J, Nigles M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL ( 1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr Sect D 54: 905–921.
  • 35
    Shimada I, Ueda T, Matsumoto M, Sakakura M, Osawa M ( 2009) Cross-saturation and transferred cross-saturation experiments. Prog NMR Spectrosc 54: 123–140.
  • 36
    Takahashi H, Nakanishi T, Kami K, Arata Y, Shimada I ( 2000) A novel NMR method for determining the interfaces of large protein–protein complexes. Nature 7: 220–223.
  • 37
    Kupce E, Wagner GW ( 1995) Homonuclear decoupling in protein spectra. J Magn Res B 109: 329–333.
  • 38
    Seo J, Jeong J, Kim YM, Hwang N, Paek E, Lee KJ ( 2008) Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase. J Proteome Res 7: 587–602.
  • 39
    Varadan R, Walker O, Pickart C, Fushman D ( 2002) Structural properties of polyubiquitin chains in solution. J Mol Biol 324: 637–647.
  • 40
    Kim KA, Song JS, Jee J, Sheen MR, Lee C, Lee TG, Ro S, Cho JM, Lee W, Yamazaki T, Jeon YH, Cheong C ( 2004) Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett 565: 181–187.
  • 41
    Ryu KS, Lee KJ, Bae SH, Kim BK, Kim KA, Choi BS ( 2003) Binding surface mapping of intra- and interdomain interactions among hHR23B, ubiquitin, and polyubiquitin binding site 2 of S5a. J Biol Chem 278: 36621–36627.
View Full Article with Supporting Information (HTML) Get PDF (951K)